EMA recommends restrictions on Multaq use

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1371, 2011-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EMEA recommends restrictions for piroxicam use

By  

Reactions Weekly, Vol. 1, Iss. 1158, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

EMEA recommends restrictions for piroxicam use

By  

Inpharma, Vol. 1, Iss. 1594, 2007-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

EMA recommends removal of sibutramine from EU markets

By  

Reactions Weekly, Vol. 1, Iss. 1286, 2010-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

The EMA's Pharmacovigilance Working Party (PhVWP) recommends that the labelling for all antipsychotics should be updated

By  

Reactions Weekly, Vol. 1, Iss. 1370, 2011-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

EMEA recommends restricting use of moxifloxacin, norfloxacin

By  

Inpharma, Vol. 1, Iss. 1649, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite